Skip to Main content Skip to Navigation
Journal articles

Lysophosphatidic acid and renal fibrosis.

Abstract : The development of fibrosis involves a multitude of events and molecules. Until now the majority of these molecules were found to be proteins or peptides. But recent data show significant involvement of the phospholipid lysophosphatidic acid (LPA) in the development of pulmonary, liver and renal fibrosis. The latest data on the role of LPA and the G-protein-coupled LPA1 receptor in the development of renal fibrosis will be discussed. LPA1-receptor activation was found to be associated with increased vascular leakage and increased fibroblast recruitment in pulmonary fibrosis. Furthermore, in renal fibrosis LPA1-receptor activation stimulates macrophage recruitment and connective tissue growth factor expression. The observations make this receptor an interesting alternative and new therapeutic target in fibrotic diseases.
Document type :
Journal articles
Complete list of metadata

Cited literature [60 references]  Display  Hide  Download
Contributor : Jean Sébastien Saulnier-Blache Connect in order to contact the contributor
Submitted on : Wednesday, May 7, 2008 - 3:01:43 PM
Last modification on : Monday, July 4, 2022 - 9:24:56 AM
Long-term archiving on: : Friday, May 28, 2010 - 6:46:34 PM




Jean-Philippe Pradère, Julien Gonzalez, Julie Klein, Philippe Valet, Sandra Grès, et al.. Lysophosphatidic acid and renal fibrosis.. Biochimica et Biophysica Acta - Molecular Cell Research, Elsevier, 2008, 1781 (9), pp.582-7. ⟨10.1016/j.bbalip.2008.04.001⟩. ⟨inserm-00277902⟩



Record views


Files downloads